Search companies or stocks...
LXEOLexeo Therapeutics, Inc. Common Stock
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an…
Current stock price of Lexeo Therapeutics, Inc. Common Stock (LXEO) stock is $4.780. The stock price is +1.70% higher in the session. The intraday range can be seen from this page. Volume of Lexeo Therapeutics, Inc. Common Stock (LXEO) stock is 468.36K.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of Lexeo Therapeutics, Inc. Common Stock (LXEO) can change with earnings, company news, and overall market sentiment. Lexeo Therapeutics, Inc. Common Stock operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Lexeo Therapeutics, Inc. Common Stock looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for LXEO on this page is -3.30. EPS on this page is -1.45. Compare those figures with peers and growth expectations before deciding if the current Lexeo Therapeutics, Inc. Common Stock price is justified.
Historical performance for Lexeo Therapeutics, Inc. Common Stock (LXEO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how LXEO reacted to past earnings and market events.
Buying Lexeo Therapeutics, Inc. Common Stock (LXEO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
